Wellington Management Group LLP Boosts Position in Oscar Health, Inc. $OSCR

Wellington Management Group LLP grew its stake in shares of Oscar Health, Inc. (NYSE:OSCR) by 65.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 603,675 shares of the company’s stock after buying an additional 239,109 shares during the period. Wellington Management Group LLP owned 0.20% of Oscar Health worth $17,217,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of OSCR. Jones Financial Companies Lllp boosted its position in shares of Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after acquiring an additional 2,242 shares during the period. Strs Ohio bought a new stake in Oscar Health during the 1st quarter worth approximately $30,000. Fifth Third Bancorp lifted its stake in Oscar Health by 148.7% in the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after purchasing an additional 1,413 shares in the last quarter. CoreCap Advisors LLC lifted its stake in Oscar Health by 526.3% in the 2nd quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock worth $34,000 after purchasing an additional 1,000 shares in the last quarter. Finally, Quarry LP boosted its holdings in Oscar Health by 439.8% in the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after purchasing an additional 1,469 shares during the period. 75.70% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Oscar Health

In other news, Director Mario Schlosser sold 880,000 shares of the company’s stock in a transaction dated Tuesday, June 23rd. The stock was sold at an average price of $29.38, for a total value of $25,854,400.00. Following the completion of the transaction, the director directly owned 480,866 shares in the company, valued at approximately $14,127,843.08. This represents a 64.66% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Mark T. Bertolini sold 624,244 shares of the stock in a transaction dated Tuesday, June 30th. The shares were sold at an average price of $28.48, for a total value of $17,778,469.12. Following the transaction, the chief executive officer owned 7,751,570 shares in the company, valued at $220,764,713.60. This trade represents a 7.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 4,241,556 shares of company stock valued at $124,280,299 over the last 90 days. 22.64% of the stock is owned by insiders.

Oscar Health Price Performance

Shares of NYSE:OSCR opened at $32.20 on Monday. The company’s fifty day moving average price is $30.43 and its 200-day moving average price is $22.74. The firm has a market capitalization of $9.94 billion, a price-to-earnings ratio of 23.00, a PEG ratio of 0.66 and a beta of 2.37. Oscar Health, Inc. has a one year low of $10.69 and a one year high of $33.55. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.09 and a quick ratio of 1.09.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.70. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The firm had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.73 billion. During the same quarter last year, the company posted ($0.89) EPS. The business’s quarterly revenue was up 70.4% on a year-over-year basis. On average, equities research analysts anticipate that Oscar Health, Inc. will post 1.54 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

OSCR has been the subject of a number of recent analyst reports. Wall Street Zen upgraded shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. UBS Group increased their price objective on Oscar Health from $20.00 to $26.00 and gave the stock a “neutral” rating in a research report on Friday, August 7th. Robert W. Baird set a $27.00 price objective on Oscar Health in a research note on Friday, August 7th. The Goldman Sachs Group restated a “neutral” rating and set a $30.00 target price on shares of Oscar Health in a research report on Tuesday, August 11th. Finally, Zacks Research upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 6th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $26.22.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.